Human Pharma Labs Profile
Key Indicators
- Authorised Capital ₹ 3.10 Cr
- Paid Up Capital ₹ 3.10 Cr
- Company Age 6 Year, 15 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.35 Cr
- Revenue Growth %
- Ebitda
- Net Worth 9900.00%
- Total Assets 371.42%
About Human Pharma Labs
Human Pharma Labs Private Limited (HPLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 24 January 2019 (Six years 15 days old ). Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.10 Cr and a paid-up capital of Rs 3.10 Cr.
The company currently has active open charges totaling ₹9.35 Cr.
Bharatkumar Dahyalal, Sunil Kanubhai, and Sunny Patel serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999GJ2019PTC106250
-
Company No.
106250
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Jan 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Human Pharma Labs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bharatkumar Dahyalal
|
Director | 24-Jan-2019 | Current |
|
Sunil Kanubhai
|
Director | 24-Jan-2019 | Current |
|
Sunny Patel
|
Director | 24-Jan-2019 | Current |
Financial Performance of Human Pharma Labs.
Human Pharma Labs Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 9900%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Human Pharma Labs?
In 2023, Human Pharma Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Umiya Enviro Project LlpBharatkumar Dahyalal is a mutual person
-
Jayvir Organics Private Limited
Bharatkumar Dahyalal is a mutual person
-
Human Pharmson Private Limited
Bharatkumar Dahyalal and Sunny Patel are mutual person
-
Harra Polymers Private Limited
Sunny Patel is a mutual person
Charges (Loans)
₹9.35 Cr
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 9.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Nov 2021 | Sidbi | ₹9.35 Cr | Open |
How Many Employees Work at Human Pharma Labs?
Unlock and access historical data on people associated with Human Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Human Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Human Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
